118 related articles for article (PubMed ID: 3114958)
1. [Donor plasma with anti-Pseudomonas aeruginosa activity as a directed-action preparation].
Nazarchuk LV
Vrach Delo; 1987 Jul; (7):96-8. PubMed ID: 3114958
[No Abstract] [Full Text] [Related]
2. [The production and use of plasma against Pseudomonas aeruginosa infection].
Popov SD; Ryzhkov SV; Stanislavskiĭ ES; Plakhotnikov AIa; Gurevich KIa; Sergienko AI; Zaĭchik VI; Popova NN; Fedorova GM; Edvabnaia LS
Voen Med Zh; 1990 Dec; (12):30-1. PubMed ID: 2127965
[No Abstract] [Full Text] [Related]
3. [The protective effect of anti-Pseudomonas blood preparations].
Nazarchuk LV; Koval' AI
Fiziol Zh (1994); 2001; 47(6):55-7. PubMed ID: 11962093
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy of specific plasma in the therapy of newborn infants with a Pseudomonas aeruginosa surgical infection].
Samsygin SA; Ovchinnikova EA; Krasovskaia TV; Dolgina EN; Ekk ND
Khirurgiia (Mosk); 1992; (11-12):61-5. PubMed ID: 1294799
[TBL] [Abstract][Full Text] [Related]
5. [Basis for the potential production of immune preparations against Pseudomonas aeruginosa from the blood of convalescent burn patients].
Povstianoĭ NE; Kolker II; Nazarchuk LV; Fedorovskaia EA; Litovchenko PP
Gematol Transfuziol; 1984 Jul; 29(7):56-8. PubMed ID: 6205938
[No Abstract] [Full Text] [Related]
6. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
[No Abstract] [Full Text] [Related]
7. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
[TBL] [Abstract][Full Text] [Related]
8. [Advisability of using donor blood immunoglobulin preparations for treating infections caused by Pseudomonas aeruginosa].
Nazarchuk LV
Klin Khir (1962); 1991; (1):23-4. PubMed ID: 1712409
[TBL] [Abstract][Full Text] [Related]
9. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
Neely AN; Holder IA
Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
[No Abstract] [Full Text] [Related]
10. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
Meitert T; Meitert E; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
[No Abstract] [Full Text] [Related]
11. [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].
Kolker II; Stanislavskiĭ ES; Grishina IA; Panova IuM; Krokhina MA
Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):29-33. PubMed ID: 6784114
[No Abstract] [Full Text] [Related]
12. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
Meitert T; Meitert E; Szegli G; Peligrad I
Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
[No Abstract] [Full Text] [Related]
13. [Sensitization to Pseudomonas aeruginosa in thermal burn patients].
Kolker II; Minkina AE; Fradkin VA; Panova IuM; Morozov SS
Klin Med (Mosk); 1982 Jun; 60(6):103-7. PubMed ID: 6811796
[No Abstract] [Full Text] [Related]
14. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
[No Abstract] [Full Text] [Related]
15. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
[TBL] [Abstract][Full Text] [Related]
16. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B
Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
[TBL] [Abstract][Full Text] [Related]
17. Vaccines and immunotherapy against Pseudomonas aeruginosa.
Döring G; Pier GB
Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
[TBL] [Abstract][Full Text] [Related]
18. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
Orłowski T; Struzyna J; Badowski A; Schiller B; Kuntze A; Kozaczek W; Goller W
Wiad Lek; 1980 Nov; 33(21):1697-701. PubMed ID: 6784349
[No Abstract] [Full Text] [Related]
19. [Detection of antibodies to Pseudomonas aeruginosa in patients with burns].
Kolker II; Stanislavskiĭ ES; Zarubina EK; Grishina IA; Panova IuM
Klin Med (Mosk); 1979 Nov; 57(11):77-81. PubMed ID: 120904
[No Abstract] [Full Text] [Related]
20. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
Moss RB
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
